SUBSCRIPTION FOR COMMON SHARESSubscription Agreement • April 25th, 2016 • Aytu Bioscience, Inc • Pharmaceutical preparations • Ontario
The undersigned (hereinafter referred to as the “Subscriber”) hereby irrevocably subscribes for and agrees to purchase from the Corporation the number of common shares of the Corporation (the “Common Shares”) set forth below for the aggregate subscription price set forth below, representing a subscription price of Cdn.$0.207 per Common Share, upon and subject to the terms and conditions set forth in this Subscription Agreement (including, for greater certainty, Section 5), including the attached “Terms and Conditions of Subscription” (including, without limitation, the representations, warranties and covenants set forth in the applicable schedules attached hereto). The Subscriber further agrees, without limitation, that the Corporation may rely upon the Subscriber’s representations, warranties and covenants contained in this Subscription Agreement. In addition to this face page, the Subscriber must also complete all applicable schedules attached hereto.
LICENSE AND SUPPLY AGREEMENT BETWEEN ACERUS PHARMACEUTICALS SRL and AYTU BIOSCIENCE, INC. Dated as of April 22, 2016 LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • April 25th, 2016 • Aytu Bioscience, Inc • Pharmaceutical preparations • New York
This LICENSE AND SUPPLY AGREEMENT (this “Agreement”) is made and effective as of April 22, 2016 (the “Effective Date”) by and among Acerus Pharmaceuticals SRL, a society with restricted liability, having its principal office at Suite B, Durants Business Center, Durants, Christ Church, Barbados (“Acerus”) and Aytu Bioscience, Inc., a Delaware corporation, having its principal office at 373 Inverness Parkway, Suite 206 Englewood, CO 80112 (“Aytu”) (each of Acerus and Aytu being a “Party,” and collectively, the “Parties”).
